{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T08:05:38Z","timestamp":1700035538501},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ejca.2005.09.031","type":"journal-article","created":{"date-parts":[[2006,1,6]],"date-time":"2006-01-06T12:11:08Z","timestamp":1136549468000},"page":"396-402","source":"Crossref","is-referenced-by-count":9,"title":["Changes in multiple myeloma epidemiology in the last thirty years: A single centre experience"],"prefix":"10.1016","volume":"42","author":[{"given":"Patrizia","family":"Zappasodi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Corso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Klersy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmatteo","family":"Pica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Mangiacavalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Varettoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Rusconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Pascutto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Lazzarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2005.09.031_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF01682035","article-title":"Presenting signs and symptoms in multiple myeloma: high percentage of stage III among patiens without apparent myeloma-associated symptoms","volume":"70","author":"Ong","year":"1995","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.ejca.2005.09.031_bib2","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0277-5379(91)90020-E","article-title":"Changing clinical presentation of multiple myeloma","volume":"27","author":"Riccardi","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2005.09.031_bib3","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1182\/blood-2003-01-0073","article-title":"Transplantation for multiple myeloma: who, when , how often? Patient selection and goals","volume":"102","author":"Blad\u00e9","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.09.031_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1470-2045(03)01077-5","article-title":"Management of multiple myeloma: a systematic review and critical appraisal of published studies","volume":"4","author":"Kumar","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2005.09.031_bib5","first-page":"609","article-title":"Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma : clinical results of 280 cases from the Spanish Registry","volume":"87","author":"Alegre","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.ejca.2005.09.031_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1998.16.2.593","article-title":"Long term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events","volume":"16","author":"Berenson","year":"1998","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.ejca.2005.09.031_bib7","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","article-title":"American society of clinical oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma","volume":"20","author":"Berenson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.09.031_bib8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2005.09.031_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomised trial of autologous transplantation and chemotherapy in multiple myeloma","volume":"335","author":"Attal","year":"1996","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2005.09.031_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.thj.6200312","article-title":"Myeloma management guidelines: a consensus report from the scientific Advisors of the International Myeloma Foundation","volume":"4","author":"Durie","year":"2003","journal-title":"Hematol J"},{"key":"10.1016\/j.ejca.2005.09.031_bib11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1365-2141.2001.03206.x","article-title":"Diagnosis and management of multiple myeloma","volume":"115","author":"UK Myeloma Forum Guidelines Working Group","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2005.09.031_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0609.1993.tb00148.x","article-title":"Initial versus deferred Melphalan-Prednisone therapy for asymtomatic multiple myeloma stage I \u2013 a randomized study","volume":"50","author":"Hjorth","year":"1993","journal-title":"Eur J Haematol"},{"issue":"26","key":"10.1016\/j.ejca.2005.09.031_bib13","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","article-title":"Single versus double autologous stem-cell transplantation for multiple myeloma","volume":"349","author":"Attal","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2005.09.031_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2141.2004.05207.x","article-title":"A population study to define the incidence and the survival of multiple myeloma in a National Health Service Region in UK","volume":"127","author":"Phekoo","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2005.09.031_bib15","first-page":"97","article-title":"Leukemias and multiple myeloma","volume":"28","author":"De Lisi","year":"2004","journal-title":"Epidemiol Prev"},{"key":"10.1016\/j.ejca.2005.09.031_bib16","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0959-8049(98)00339-6","article-title":"Variation in survival of adult patients with haematological malignancies in Europe since 1978","volume":"34","author":"Carli","year":"1998","journal-title":"Eur J Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.ejca.2005.09.031_bib17","doi-asserted-by":"crossref","first-page":"v61","DOI":"10.1093\/annonc\/mdg754","article-title":"Eurocare-3: survival of cancer patients diagnosed 1990\u201394, results and commentary","volume":"14","author":"Sant","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2005.09.031_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2141.1999.01406.x","article-title":"Intensive treatment for multiple myeloma: where do we stand?","volume":"106","author":"Lokhorst","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2005.09.031_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejca.2005.09.031_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","article-title":"Cancer statistics 2000","volume":"50","author":"Greenlee","year":"2000","journal-title":"CA: Cancer J Clin"},{"issue":"17","key":"10.1016\/j.ejca.2005.09.031_bib21","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/archinte.158.17.1889","article-title":"Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution","volume":"158","author":"Blad\u00e8","year":"1998","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.ejca.2005.09.031_bib22","doi-asserted-by":"crossref","first-page":"#3465","DOI":"10.1182\/blood.V104.11.3465.3465","article-title":"Early mortality following diagnosis of multiple myeloma; analysis of patients entered into the UK Medical Research Council Trials 1980\u20132002","volume":"104","author":"Augustson","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.09.031_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V93.1.55","article-title":"Total therapy with tandem transplant for newly diagnosed multiple myeloma","volume":"93","author":"Barlogie","year":"1999","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.ejca.2005.09.031_bib24","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High dose chemotherapy with hematopoietic stem-cell rescue in multiple myeloma patients","volume":"348","author":"Child","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2005.09.031_bib25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1365-2141.2000.02012.x","article-title":"Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients","volume":"109","author":"Lahuerta","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2005.09.031_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2003-04-1045","article-title":"Treatment of multiple myeloma","volume":"103","author":"Barlogie","year":"2004","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ejca.2005.09.031_bib27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4065\/79.7.867","article-title":"Clinical course of patients with relapsed multiple myeloma","volume":"79","author":"Kumar","year":"2004","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.ejca.2005.09.031_bib28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bmt.1704713","article-title":"Extramedullary versus medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome","volume":"34","author":"Zeiser","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejca.2005.09.031_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0609.1996.tb01340.x","article-title":"relapse of multiple myeloma in extramedullary sites after autologous bone marrow transplantation","volume":"56","author":"Sanfructuoso","year":"1996","journal-title":"Eur J Haematol"},{"issue":"6","key":"10.1016\/j.ejca.2005.09.031_bib30","first-page":"609","article-title":"Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry","volume":"87","author":"Alegre","year":"2002","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.ejca.2005.09.031_bib31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0","article-title":"Zoledronic acid reduces skeletal related events in patients with osteolytic metastases","volume":"91","author":"Berenson","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2005.09.031_bib32","first-page":"394","article-title":"Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role for the identification of high risk patients","volume":"86","author":"Corso","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.ejca.2005.09.031_bib33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00277-003-0699-9","article-title":"Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implications","volume":"82","author":"Corso","year":"2003","journal-title":"Ann Haematol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905010117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905010117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T00:13:31Z","timestamp":1586650411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804905010117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0959804905010117"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2005.09.031","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}